Company / Cost of Revenue
Astrana Health, Inc. Cost of Revenue History
FY2017-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$596.1M
FY2021
5-year range
$596.1M / $596.1M
FY2017-FY2021
Trend
+10.6%
vs FY2020
Sector context
#62 of 113
Health Care
What the data says
At $596M, Astrana Health, Inc.'s cost of revenue ranks #52 of 113 in the Health Care sector. Cost of Revenue has increased for 4 consecutive years, from $273M in FY2017 to $596M in FY2021.
Based on SEC 10-K filings.
$596M in FY2021 with a 3-year CAGR of +18.2%.
Increased from $468M to $596M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +18.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#52 of 113 in Health CareTop 45% of 113This company $596.1M Sector average $11.3B
▼
-94.7% below sector average
Key checks
Key Insights
- Astrana Health, Inc.'s cost of revenue has grown for 4 consecutive years.
- 3-year CAGR of +18.2%, indicating consistent growth.
- In FY2021, cost of revenue increased 10.6% year-over-year.
- Ranks #62 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $596.1M | +10.6% |
| FY2020 | $539.2M | +15.3% |
| FY2019 | $467.8M | +29.5% |
| FY2018 | $361.1M | +32.1% |
| FY2017 | $273.5M | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026